Critical cellular events at the palatal medial edge epithelium (MEE) occur in unperturbed mammalian palatogenesis, the molecular control of which involves a number of growth factors including transforming growth factor β3 (TGFβ3). Apert syndrome is a monogenic human disorder in which cleft palate has been significantly correlated to the fibroblast growth factor receptor (FGFR) 2-Ser252Trp mutation. We report the relative expression of these genes in human palatogenesis.
Methods:
The expression of the IgIIIa/b and IgIIIa/c transcript isoforms of FGFR2 and the proteins FGFR1, FGFR2, and FGFR3 was studied in situ throughout the temporospatial sequence of human palatal shelf fusion and correlated with the expression of TGFβ3. In addition, the immunolocalization of the ligand FGFs 2, 4, and 7 was undertaken together with the intracellular transcription factor STAT1, which is activated by FGFR signaling.
Results:
FGFRs are differentially expressed in the mesenchyme and epithelia of fusing palatal shelves, in domains overlapping those of their ligands FGF4 and FGF2 but not FGF7. Coexpression is seen with TGFβ3, which is implicated in MEE dynamics and FGF and FGFR upregulation, and STAT1, an intracellular transcription factor that mediates apoptosis.
Conclusions:
The coregulation of molecules of the FGFR signaling pathway with TGFβ3 throughout the stages of human palatal fusion suggests their controlling influence on apoptosis and epitheliomesenchymal transdifferentiation at the MEE. Experimental evidence links FGFR2-IgIIIa/b loss of function with palatal clefting, and these correlated data suggest a unique pathological mechanism for Apert cleft palate.
BrittoJ.A., RagoowansiR.H., SommerladB.C.. Double tongue, intraoral anomalies, and cleft palate–case reports and a discussion of developmental pathology.Cleft Palate Craniofac J.2000; 37: 410–415.
3.
BrunetC.L., SharpeP.M., FergusonM.W.. Inhibition of TGF-beta 3 (but not TGF-beta 1 or TGF-beta 2) activity prevents normal mouse embryonic palate fusion.Int J Dev Biol.1995; 39: 345–355.
4.
CaretteM.J., FergusonM.W.. The fate of medial edge epithelial cells during palatal fusion in vitro: an analysis by DiI labelling and confocal microscopy.Development.1992; 114: 379–388.
5.
ChanC-TJ, ThorogoodP.. Pleiotropic features of syndromic craniosynostoses correlate with differential expression of fibroblast growth factor receptors 1 and 2 during human craniofacial development.Pediatr Res.1999; 45: 1–8.
6.
ChaoM.V.. Growth factor signaling: where is the specificity?Cell.1992; 68: 995–997.
7.
ChenL., AdarR., YangX., MonsonegoE.O., LiC., HauschkaP.V., YayonA., DengC.X.. Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis.J Clin Invest.1999; 104: 1517–1525.
8.
DanilenkoD.M., RingB.D., YanagiharaD., BensonW., WiemannB., StarnesC.O., PierceG.F.. Keratinocyte growth factor is an important endogenous mediator of hair follicle growth, development, and differentiation. Normalization of the nu/nu follicular differentiation defect and amelioration of chemotherapy-induced alopecia.Am J Pathol.1995; 147: 145–154.
9.
De MoerloozeL., Spencer-DeneB., RevestJ., HajihosseiniM., RosewellI., DicksonC.. An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis.Development.2000; 127: 483–492.
10.
DionneC.A., CrumleyG., BellotF., KaplowJ.M., SearfossG., RutaM., BurgessW.H., JayeM., SchlessingerJ.. Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors.EMBO J.1990; 9: 2685–2692.
11.
FitchettJ.E., HayE.D.. Medial edge epithelium transforms to mesenchyme after embryonic palatal shelves fuse.Dev Biol.1989; 131: 455–474.
12.
FragaleA., TartagliaM., BernardiniS., Di StasiA.M., Di RoccoC., VelardiF., TetiA., BattagliaP.A., MigliaccioS.. Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders.Am J Pathol.1999; 154: 1465–1477.
13.
FunatoN., MoriyamaK., ShimokawaH., KurodaT.. Basic fibroblast growth factor induces apoptosis in myofibroblastic cells isolated from rat palatal mucosa.Biochem Biophys Res Comm.1997; 240: 21–26.
14.
GibbinsJ.R., BrentS., SrivastavaM., GaribottoN., TazawaY.M., CameronA., HunterN.. Rapid disappearance of the medial epithelial seam during palatal fusion occurs by multifocal breakdown that is preceded by expression of alpha smooth muscle actin in the epithelium.Int J Dev Biol.2000; 44: 223–231.
15.
GriffithC.M., HayE.D.. Epithelial-mesenchymal transformation during palatal fusion: carboxyfluorescein traces cells at light and electron microscopic levels.Development.1992; 116: 1087–1099.
16.
HartK.C., RobertsonS.C., KanemitsuM.Y., MeyerA.N., TynanJ.A., DonoghueD.J.. Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4.Oncogene.2000; 19: 3309–3320.
17.
KaartinenV., CuiX.M., HeisterkampN., GroffenJ., ShulerC.F.. Transforming growth factor-beta3 regulates transdifferentiation of medial edge epithelium during palatal fusion and associated degradation of the basement membrane.Dev Dyn.1997; 209: 255–260.
18.
KaartinenV., VonckenJ.W., ShulerC., WarburtonD., BuD., HeisterkampN., GroffenJ.. Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction.Nat Genet.1995; 11: 415–421.
19.
KayE.P., LeeM.S., SeongG.J., LeeY.G.. TGF-betas stimulate cell proliferation via an autocrine production of FGF-2 in corneal stromal fibroblasts.Curr Eye Res.1998; 17: 286–293.
20.
KreiborgS., CohenM.M.J.. The oral manifestations of Apert syndrome.J Craniofac Genet Dev Biol.1992; 12: 41–48.
21.
Legeai-MalletL., Benoist-LasselinC., DelezoideA.L., MunnichA., BonaventureJ.. Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thanatophoric dysplasia [published erratum appears in J Biol Chem 1998; 273: 19358].J Biol Chem.1998; 273: 13007–13014.
22.
LomriA., LemonnierJ., HottM., de ParsevalN., LajeunieE., MunnichA., RenierD., MarieP.J.. Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome.J Clin Invest.1998; 101: 1310–1317.
23.
Martinez-AlvarezC., O'KaneS., TayaY., FergusonM.W.. Palate development in the TGF-beta 3 knockout mouse. Low vacuum scanning electron microscopy reveals changes in the medial edge epithelium.Int J Dev Biol.1996; (suppl 1): 115S–116S.
MikiT., BottaroD.P., FlemingT.P., SmithC.L., BurgessW.H., ChanA.M., AaronsonS.A.. Determination of ligand binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene.Proc Natl Acad Sci USA.1992; 89: 246–250.
26.
MoriC., NakamuraN., OkamotoY., OsawaM., ShiotaK.. Cytochemical identification of programmed cell death in the fusing fetal mouse palate by specific labelling of DNA fragmentation.Anat Embryol. (Berl)1994; 190: 21–28.
Orr-UrtregerA., BedfordM.T., BurakovaT., ArmanE., ZimmerY., YayonA., GivolD., LonaiP.. Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2).Dev Biol.1993; 158: 475–486.
29.
PetersonS.J., PruzanskyS.. Palatal anomalies in the syndromes of Apert and Crouzon.Cleft Palate J.1974; 11: 394–403.
30.
Peterson-FalzoneS.J., PruzanskyS., ParrisP.J., LafferJ.L.. Nasopharyngeal dysmorphology in the syndromes of Apert and Crouzon.Cleft Palate J.1981; 18: 237–250.
31.
PolkinghorneJ., HoffenbergR., KennedyI., MacintyreS.. Review of the guidance on the research use of fetuses and fetal material.London: HMSO;1989.
SharpeP.M., BrunetC.L., ForemanD.M., FergusonM.W.J.. Localisation of acidic and basic fibroblast growth factors during mouse palate development and their effects on mouse palate mesenchyme cells in vitro.Arch Dev Biol.1993; 202: 132–143.
34.
ShimizuT., KitamuraS., KinouchiK., FukumitsuK.. A rare case of upper airway obstruction in an infant caused by basal encephalocele complicating facial midline deformity.Paediatr Anaesth.1999; 9: 73–76.
35.
ShulerC.F., GuoY., MajumderA., LuoR.Y.. Molecular and morphologic changes during the epithelial-mesenchymal transformation of palatal shelf medial edge epithelium in vitro.Int J Dev Biol.1991; 35: 463–472.
36.
ShulerC.F., HalpernD.E., GuoY., SankA.C.. Medial edge epithelium fate traced by cell lineage analysis during epithelial-mesenchymal transformation in vivo.Dev Biol.1992; 154: 318–330.
37.
SlaneyS.F., OldridgeM., HurstJ.A., Moriss-KayG.M., HallC.M., PooleM.D., WilkieA.O.. Differential effects of FGFR2 mutations on syndactyly and cleft palate in Apert syndrome.Am J Hum Genet.1996; 58: 923–932.
38.
SmileyG.R., DixonA.D.. Fine structure of midline epithelium in the developing palate of the mouse.Anat Rec.1968; 161: 293–310.
39.
SuW-CS, KitagawalM., XueN., XieB., GarofaloS., ChoJ., DengC., HortonW.A., FuX-Y. Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type 11 dwarfism.Nature.1997; 386: 288–292.
40.
SunD., VanderburgC.R., OdiernaG.S., HayE.D.. TGFbeta3 promotes transformation of chicken palate medial edge epithelium to mesenchyme in vitro.Development.1998; 125: 95–105.
41.
TayaY., O'KaneS., FergusonM.W.. Pathogenesis of cleft palate in TGF-beta3 knockout mice.Development.1999; 126: 3869–3879.
42.
WernerS., SmolaH., LiaoX., LongakerM.T., KriegT., HofschneiderP.H., WilliamsL.T.. The function of KGF in morphogenesis of epithelium and reepithelialization of wounds.Science.1994; 266: 819–822.
